Approval · Notice of Compliance 2740 · 1998
CLONIDINE: Notice of Compliance 2740
Issued November 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2740
- Date
- November 27, 1998
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Revised product monograph
- Therapeutic class
- Antihypertensive agent
- Canadian reference product
- APR-CLONIDINE (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLONIDINE | Not yet assigned | — |
Medicinal ingredients
- CLONIDINE HYDROCHLORIDE 1 MG per TAB
- CLONIDINE HYDROCHLORIDE 2 MG per TAB